西尼罗热研究进展

摘要/Abstract

摘要：

西尼罗病毒属黄病毒科,为单股正链RNA病毒。它感染人类导致发展为西尼罗热。主要宿主动物为鸟类,蚊虫为传播媒介。该病在欧洲及中亚地区散发,小规模流行,于1999年在美国暴发流行及随后在北美的流行引起极大关注。另外,蚊虫叮咬以外的传播途径,如输血、器官移植、母婴传播等日益受到人们的重视,且目前还没有预防该病的疫苗。该病具有传染性强,重症病例多和病死率高的特点,对人类健康和生命安全造成较大威胁。现就西尼罗热的病原学、流行病学、临床学、实验室诊断及预防控制的研究进展做一综述。

关键词: 西尼罗热, 西尼罗病毒, 病原学, 流行病学

Abstract:

West Nile virus (WNV) is a positive, single strand RNA virus belonging to Flavivridae that causes infectious West Nile fever (WNF) in human beings. Birds are the main host of WNV, and mosquitoes the main transmitting vector. WNF has been endemic in the Europe and middle-west Asia for decades. The outbreak of WNF in the United States in 1999 and subsequent epidemics in North America in the following years have caused great concerns. Moreover, greater concerns have arisen from other transmitting routes besides mosquito bites, such as blood transfusion, organ transplantation and vertical transmission. As there is no vaccine available for prevention of WNF, the condition is associated with significant threat to public health and life security due to the high infection rate, the increasing number of severe cases and high mortality rate. This paper unfolds a comprehensive discussion about the etiology, epidemiology clinical, lab diagnosis, prevention and surveillance of WNF.

Key words: West Nile fever, West Nile virus, Etiology, Epidemiology

中图分类号:

R373.3

刘芬, 张海林. 西尼罗热研究进展[J]. 中国媒介生物学及控制杂志, 2012, 23(1): 82-85.

LIU Fen, ZHANG Hai-lin. Advances in research on West Nile fever[J]. Chines Journal of Vector Biology and Control, 2012, 23(1): 82-85.

参考文献

[1] Lanciotti RS,Ebel GD,Deubel V,et al. Complete genome sequencesand phylogenetic analysis of West Nile virus strains isolated fromthe United States,Europe,and the Middle East
[J]. Virology,2002,298(1):96-105.

[2] Petersen R,Roehrrig JT. West Nile virus:A reemerging globalpathogen
[J]. Emerg Infect Dis,2001,7(4):611-614.

[3] Macdonald J,Tonry RA,Hall B,et al. NS1 protein secretion duringthe acute phase of West Nile virus infection
[J]. Virol,2005,79(22):13924-13933.

[4] Wilson JR,Sessions PF,Leon MA,et al. West Nile virusnonstructural protein 1 inhibits TLR3 Signal Tranduction
[J]. JVirol,2008,82(17):8262-8271.

[5] Liu WJ,Wang XJ,Clark DC,et al. A single amino acid substitutionin the West Nile virus nonstructural protein NS2A disables itsability to inhibit alpha/beta interferon induction and attenuates virusvirulence in mice
[J]. Virol,2006,80(5):2396-2404.

[6] Liu WJ,Wang XJ,Mokhonov VV,et al. Inhibition of interferonsignaling by the New York 99 strain and Kunjin subtype of WestNile virus involves blockage of STAT1 and STAT2 activation bynonstructural proteins
[J]. Virol,2005,79(3):1934-1942.

[7] Kummerer BM,Rice CM. Mutations in the yellow fever virusnonstructural protein NS2A selectively block production ofinfectious particles
[J]. Virol,2002,76(10):4773-4784.

[8] Malet H,Egloff M,Selisko B,et al. Crystal structure of the RNApolymerase domain of the West Nile virus nonstructural protein 5
[J]. J Biol Chem,2007,282(14):10678-10689.

[9] 俞永新. 近年来西尼罗热的流行现状及其流行毒株的表型和基因型特性
[J]. 国外医学:流行病学传染病学分册,2005,32(3):129-134.

[10] Shrestha B,Diamond MS. Fas Ligand interactions contribute toCD8 T - cell - mediated controlof West Nile virus infection in thecentral nervous system
[J]. Am Soc Microbiol,2007,81(21):11749-11757.

[11] Elizabeth S,McCandless EE,Klein RS,et al. CD40-CD40 ligandinteractions promote trafficking of CD8_ T cells into the brain andprotection against West Nile virus encephalitis
[J]. Am SocMicrobiol,2007,81(18):9801-9811.

[12] Daffs S,Samuel AM,Suthar SM,et al. Interferon regulatory factorIRF-7 induces the antiviral alpha interferon response and protectsagainst1 Lethal West Nile virus infection
[J]. J Virol,2008,82(17):8465-8475.

[13] Daffis S,Samuel AM,Suthar SM,et al. Toll-like receptor 3 has aprotective role against West Nile virus infection
[J]. J Virol,2008,82(21):10349-10358.

[14] Arjona A,Michel L,Karen A,et al. West Nile virus envelope proteininhibits dsRNA-induced innate immune responses
[J]. J Immunol,2007,179(12):8403-8409.

[15] Laurent-Rolle M,Boer EF,Lubick KJ,et al. The NS5 protein ofthe virulent West Nile virus NY99 strain is a potent antagonist oftypeⅠ interferon-mediated JAK-STAT signaling
[J]. J Virol,2010,84(7):3503-3515.

[16] Lim JK,Lisco A,McDermott DH,et al. Genetic variation in OAS1is a risk factor for initial infection with West Nile virus in man
[J].PLoS Pathog,2009,5(2):e1000321.

[17] Szretter KJ,Samuel MA,Gilfillan S,et al. The immune adaptormolecule SARM modulates tumor necrosis factor alpha productionand microglia activation in the brainstemand restricts West Nilevirus pathogenesis
[J]. J Virol,2009,83(18):9329-9338.

[18] Kilpatrick AM,Meola MA,Moudy RM,et al. Temperature,viralgenetics,and the transmission of West Nile virus by Culex pipiensmosquitoes
[J]. PLoS Pathog,2008,4(6):e1000092.

[19] Amore G,Bertolotti L,Hamer GL,et al. Multi-year evolutionarydynamics og West Nile virus in suburban Chicago,USA,2005-2007
[J]. Phil Trans R Soc B,2010,365(1548):1871-1878.

[20] Lindsey NP,Hayes EB,Staples JE,et al. West Nile virus diseasein children,United States,1999-2007
[J]. Pediatrics,2009,123(6):1084-1089.

[21] Ludwig GV,Calle PP,Mangiafico JA,et al. An outbreak of WestNile virus in a New York city captive wildlife population
[J]. Am JTrop Med Hyg,2002,67(1):67-75.

[22] Pealer LN,Marfin AA,Petersen LR,et al. Transmission of WestNile virus through blood transfusion in the United States in 2002
[J]. N Engl J Med,2003,349(13):1236-1245.

[23] Centers for Disease Control and Prevention. West Nile virus infectionin organ donor and transplant recipients－Georgia and Florida 2002
[J]. Morb Mortal Wkly Rep,2002,51(35):790.

[24] Centers for Disease Control and Prevention. Laboratory-acquiredWest Nile virus infections－ United States,2002
[J]. Morb MortalWkly Rep,2002,51(50):1133-1135.

[25] Centers for Disease Control and Prevention. Provisional surveillancesummary of the West Nile virus epidemic－United States,January-November 2002
[J]. Morb Mortal Wkly Rep,2002,51(50):1129-1133.

[26] Hinckley AF,O'Leary DR, Hayes EB. Transmission of West Nilevirus through human breast milk seems to be rare
[J]. Pediatrics,2007,119(3):666-671.

[27] Murray K,Walker C,Herrington E,et al. Persistent infection withWest Nile virus years after initial infection
[J]. J Inf Dis,2010,201(1):2-4.

[28] Hayes CG. West Nile virus:Uganda,1937,to New York city,1999
[J]. Ann N Y Acad Sci,2001,951(12):25-37.

[29] Petersen LR,Marfin AA. West Nile virus:A primer for the clinician
[J]. Ann Intern Med,2002,137(3):173-179.

[30] Bode AV,Sejvar JJ,Pape WJ,et al. West Nile virus disease:adescriptive study of 228 patients hospitalized in a 4-county regionof Colorado in 2003
[J]. Clin Infect Dis,2006,42(9):1234-1240.

[31] Sejvar JJ,Haddad MB,Tierney BC,et al. Neurologic manifestationsand outcome of West Nile virus infection
[J]. JAMA,2003,290(4):511-515.

[32] Tyler KL,Pape J,Goody RJ,et al. CSF findings in 250 patientswith serologically confirmed West Nile virus meningitis andencephalitis
[J]. Neurology,2006,66(3):361-365.

[33] Petropoulou KA,Gordon SM,Prayson RA,et al. West Nile virusmeningoencephalitis:MR imaging findings
[J]. AJNR Am JNeuroradiol,2005,26(8):1986-1995.

[34] Stone WB,Therrien JE,Benson R,et al. Assays to detect West Nilevirus in dead birds
[J]. Emerg Infect Dis,2005,11(9):1770-1773.

[35] Burkhalter KL,Lindsay R,Anderson R,et al. Evaluation ofcommercial assays for detecting West Nile virus antigen
[J]. J AmMosqn Control Assoc,2006,22(1):64-69.

[36] Qin M,Yuan ZM,Shi PY. A virus-type specific serological diagnosisof flavivirus infection using virus - like particles
[J]. VirologicaSinica,2009,24(2):136-145.

[37] Wong SJ,Boyle RH,Demarrest VL,et al. Immunoassay targetingnonstructural protein 5 to differentiate West Nile virusinfection from dengue and St. Louis encephal it is virus infectionsand from flavivirus vaccination
[J]. J Clin Microbiol,2003,41(9):4217-4223.

[38] Lanciotti RS,Kerst AJ. Nucleic acid sequence-based amplificationassays for rapid detection of West Nile and St. Louis encephalitisviruses
[J]. J Clin Microbiol,2001,39(12):4506-4513.

[39] 詹爱军,王新卫,花群义,等. 西尼罗热液相芯片快速检测方法的初步建立
[J]. 扬州大学学报:农业与生命科学版,2010,31(1):1-5.

[40] Seino KK,Long MT,Gibbs EP,et al. Comparative efficacies ofthree commercially available vaccines against West Nile virus(WNV) in a short - duration challenge trial involving an equineWNV encephalitis model
[J]. Clin Vaccine Immunol,2007,14(11):1465-1471.

[41] Chung KM,Thompson BS,Fremont DH,et al. Antibody recognitionof cell surface - associated NS1 triggers Fc - γ receptor - mediatedphagocytosis and clearance of West Nile virus-infected cells
[J]. JVirol,2007,81(17):9551-9555.

[42] Biedenbender R,Bevilacqua J,Gregg AM,et al. Phase Ⅱ,randomized,double-blind,placebo-controlled,multicenter studyto investigate the immunogenicity and safety of a West Nile virusvaccine in healthy adults
[J]. J Inf Dis,2011,203(1):75-84.